6 distinct forms of depression identified by AI in brain study

, which could explain why some people don't respond to traditional treatments for the condition, such as antidepressants and talk therapy.

In a new study, researchers analyzed brain scans of more than 800 patients who'd been diagnosed with depression and anxiety. These scans were taken as the patients were resting and while they were engaged in different tasks designed to test how their brains functioned.

.

.

For instance, patients who had high activity in regions of the brain associated with processing emotions were more likely to display feelings of anhedonia — the inability to experience pleasure — than other patients. They also performed worse than the others on tasks that assessed their executive function, or capacity to focus and manage activities.

Related: 'Scent therapy' helps unlock memories in people with depression, trial finds

, co-senior study author and a professor of psychiatry and behavioral sciences at Stanford University, told Live Science.

— such as depressed mood, insomnia and fatigue — for at least two weeks. However, this leaves a lot of possible symptom combinations.

A better understanding of the biological reasons for a particular symptom of depression may help patients feel like they're understood and may help reduce any stigma associated with their condition, Williams said.

In a separate analysis, the team found that three of the six subtypes that they'd identified showed signs that they were either more or less likely to respond to specific treatments. For example, patients who had high activity in cognitive regions of the brain responded better to an antidepressant called venlafaxine, commonly marketed under the brand name Effexor, than other subtypes did.

to determine if antidepressants, for instance, will have an effect on a particular patient's symptoms.

"To see that we can predict better outcomes on specific treatments really makes it [this work] really worthwhile," Williams said.

, a professor of psychiatry at the University of Pittsburgh, who was not involved in the research, told Live Science in an email.

The idea that neuroimaging-derived subtypes of depression could have important clinical differences and potentially different treatment responses could be a critical step in moving towards personalized care, he said.

The researchers now plan to test their approach on more people. They'd also like to look at the response of each subtype to other treatment options.

The hope is that someday, doctors might be able to match patients to the type of treatment that is most likely to work for them based on their subtype, Williams said.